Page 2 - Ngs Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ngs testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ngs Testing Today - Breaking & Trending Today

NSCLC: Selecting a Molecular Testing Assay and Interpreting Results

Shared perspective on the armamentarium of molecular testing assays in non–small cell lung cancer and how results can be best interpreted when selecting treatment. ....

Treating Uncommon , Molecular Testing Assay , Non Small Cell Lung Cancer , Lung Cancer , Metastatic Lung Cancer , Metastatic Nsclc , Molecular Testing , Biomarker Testing , Tissue Testing , Tissue Biopsy , Liquid Biopsy , Ctdna Testing , Circulating Tumor Dna , Pcr Testing , Fish Testing , Ngs Testing , Next Generation Sequencing , Rna Testing , Broad Molecular Profiling , Clinical Trials , Novel Therapy , Targeted Therapy ,

Evolving Field of Molecular Testing in Non–Small Cell Lung Cancer

Expert oncologists reflect on the current state of molecular testing in patients with non–small cell lung cancer and how it has impacted treatment pathways. ....

Treating Uncommon , Molecular Testing , Small Cell Lung Cancer , Non Small Cell Lung Cancer , Lung Cancer , Metastatic Lung Cancer , Metastatic Nsclc , Biomarker Testing , Tissue Testing , Tissue Biopsy , Liquid Biopsy , Ctdna Testing , Circulating Tumor Dna , Rna Testing , Rna Test , Immune Checkpoint Inhibitors , Targeted Therapy , Egfr Mutation , Walk Testing , Kras G12c , Met Alteration , Nccn Guidelines , Ngs Testing , Next Generation Sequencing ,

Perioperative Treatment in Early-Stage NSCLC: AEGEAN Study

David Harpole, MD, discusses study design, results and clinical implications of the AEGEAN study of perioperative immunotherapy (neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in the treatment of early-stage NSCLC ....

David Harpole , Recent Updates , Translating Evidence , Clinical Practice , Early Nsclc , Non Small Cell Lung Cancer , Asco 2023 , Localized Disease , Molecular Testing , Liquid Biopsy , Tissue Biopsy , Ngs Testing ,

Inequalities Within and Between Practices Contribute to NGS Testing Disparities in NSCLC

A study presented at the American Society of Clinical Oncology Annual Meeting found practice- and provider-level racial and ethnic inequities in rates of next-generation sequencing (NGS) testing for patients with advanced non–small cell lung cancer (NSCLC) treated in the community setting. ....

United States , Latinx White , Gregorya Vidal , American Society Of Clinical Oncology Annual Meeting , Flatiron Health , Research Institute , Cancer Center , Inequalities Within , Between Practices Contribute , American Society , Clinical Oncology Annual Meeting , West Cancer Center , Clinical Oncology Annual , Latinx Black , Lung Cancer , Ngs Testing , Non Small Cell Lung Cancer ,

Role for IO Therapy in Advanced NSCLC With Concomitant KRAS and KEAP1/STK11 Mutations

Key opinion leaders in the field of non–small cell lung cancer management discuss the role of immunotherapy in patients with concomitant KRAS and KEAP1/STK11 mutations. ....

Recent Updates , Translating Evidence , Clinical Practice , Lung Cancer , Non Small Cell Lung Cancer , Trio Therapy , Immune Checkpoint Inhibitors , Metastatic Nsclc , Metastatic Lung Cancer , Kras Stk11 , Kras Keap1 , Poseidon Study , Poseidon Trial , Ngs Testing , Next Generation Sequencing , Molecular Testing , Genetic Testing ,